# A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

> **NCT00328432** · PHASE1 · COMPLETED · sponsor: **University of Kansas** · enrollment: 100 (—)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** celecoxib 400 mg bid

## Key facts

- **NCT ID:** NCT00328432
- **Lead sponsor:** University of Kansas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 100 (—)
- **Last updated:** 2008-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00328432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00328432, "A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00328432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*